Silver Lake Hospital to pay $19M over Medicare false claims
By 
Kyle Brasseur2024-01-17T17:37:00
New Jersey-based Silver Lake Hospital agreed to pay more than $18.6 million as part of a settlement with the Department of Justice (DOJ) addressing allegations of false claims submitted to Medicare for inpatient cost outlier payments.
The settlement, announced Tuesday by the DOJ, also resolves allegations Silver Lake violated the Federal Debt Collection Procedures Act (FDCPA) regarding the transfer of millions of dollars in the hospital’s money to investors without receiving equivalent value in return. As a result, Silver Lake’s principal investor and a Florida-based fund manager that serves the hospital’s investors agreed to pay $12 million in restitution.
The entire Silver Lake settlement amount is also restitution, according to the settlement agreement.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefDrug company and CEO pay $47 million over alleged kickbacks and false claims
A pharmaceutical company and its chief executive have agreed to pay $47 million to settle allegations first brought by whistleblowers, that the company paid kickbacks and filed false claims, the Department of Justice said.
-
News BriefDOJ orders Baptist Health to pay $1.5M over discount policy false claims
Florida-based Baptist Health System agreed to pay $1.5 million to settle self-disclosed violations of the False Claims Act for allegedly offering discounts to patients to induce purchases or refer services reimbursed by Medicare.
-
News BriefDOJ lawsuit charges Regeneron with inflating Medicare costs
New York-based Regeneron Pharmaceuticals is being sued by the Department of Justice for allegedly flouting Medicare’s price reporting requirements.
More from Regulatory Enforcement
-
ArticleTariff evasion enforcement: The new FCPA
Companies that import goods into the United States will face heightened enforcement scrutiny for attempted acts of customs fraud, including tariff evasion, under the Trump administration. Thus, chief compliance officers and in-house counsel face a new kind of pressure to ensure they are mitigating risk in this area.
-
ArticleFormer COO of plastics importer faces up to five years for customs falsifications
The chief operating officer of a plastic resin importer has pleaded guilty to intentionally falsifying documents to avoid paying tariffs on goods from China, the Department of Justice (DOJ) announced.
-
ArticleCybercrime against banks and account holders takes hit from FBI
Federal investigators have announced progress in dismantling an online criminal operation that steals bank account information by mimicking legitimate bank websites.